Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  NCI SPORE III.                    

*Date:*                         September 19-20, 2018.                    

*Time:*                         5:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Wlodek Lopaczynski, M.D., Ph.D.,  Scientific Review Officer,  Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W514, Bethesda, MD 20892-9750, 240-276-6340,                         *lopacw@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP 4 for Provocative Questions.                    

*Date:*                         September 21, 2018.                    

*Time:*                         7:30 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Clifford W. Schweinfest, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343,                         *schweinfestcw@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-1 for Provocative Questions.                    

*Date:*                         October 4, 2018.                    

*Time:*                         7:30 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville, MD 20850.                    

*Contact Person:*                         Hasan Siddiqui, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240, Bethesda, MD 20892-9750, 240-276-5122,                         *hasan.siddiqui@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-3 for Provocative Questions.                    

*Date:*                         October 9, 2018.                    

*Time:*                         8:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Adriana Stoica, Ph.D.,  Scientific Review Officer,  Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368,                         *Stoicaa2@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Traceback Testing: Identification and Genetic Counseling of Mutation Carriers (U01).                    

*Date:*                         October 10, 2018.                    

*Time:*                         11:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Anita T. Tandle, Ph.D.,  Scientific Review Officer,  Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5007,                         *tandlea@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-5 for Provocative Questions.                    

*Date:*                         October 18-19, 2018.                    

*Time:*                         6:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Contact Person:*                         Byeong-Chel Lee, Ph.D.,  Scientific Review Officer,  Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755,                         *byeong-chel.lee@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-1 NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         October 25, 2018.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Zhiqiang Zou, M.D., Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372,                         *zouzhiq@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  NCI U01 Review: Integrating Biospecimens into Clinical Assay Development.                    

*Date:*                         November 15, 2018.                    

*Time:*                         12:00 p.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W116, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Klaus B. Piontek, Ph.D.,  Scientific Review Officer,  Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W116, Bethesda, MD 20892-9750, 240-276-7849,                         *klaus.piontek@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated:  August 20, 2018. 

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-18399 Filed 8-24-18; 8:45 am]

BILLING CODE 4140-01-P